Search
Vernal Keratoconjunctivitis
go.drugbank.com/conditions/DBCOND0036467Synonyms: Allergy to pollen, Allergy to pollen (finding)Copper
go.drugbank.com/drugs/DB09130ApprovedInvestigationalIt is important to the function of many enzymes including cytochrome c oxidase, monoamine oxidase and superoxide dismutase [FDA Label].
Mixtures: Classic Swiss One 10 Multivitamin and Mineral Tab, Protect Plus SO 60Products: ParaGard T 380A, Copper Chelate - 5mg TabHemolytic Disease of Newborn
go.drugbank.com/conditions/DBCOND0028919Drugs: Albumin humanSynonyms: Hemolytic disease due to isoimmunization NOS (disorder), Haemolytic disease of fetus and newborn due to isoimmunisationClidinium
go.drugbank.com/drugs/DB00771ApprovedIt is used for the treatment of peptic ulcer disease and also to help relieve abdominal or stomach spasms or cramps due to colicky abdominal pain, diverticulitis, and irritable bowel syndrome. … Clidinium is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract.
Mixtures: LIBRAX DRAJE, 100 ADET, LIBRAX DRAJE, 500 ADETMetastatic Colorectal Cancer (CRC)
go.drugbank.com/conditions/DBCOND0134580Synonyms: Metastasis to large intestine, Metastases to large intestine(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
go.drugbank.com/drugs/DB08564ExperimentalSynonyms: (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamideTriprolidine
go.drugbank.com/drugs/DB00427ApprovedFirst generation histamine H1 antagonist used in allergic rhinitis; asthma; and urticaria. It is a component of cough and cold medicines. It may cause drowsiness.
Mixtures: TRIFEN 100 ML SUS., A-FERIN DECO ŞURUP, 100 MLProducts: M-Hist PDVorapaxar
go.drugbank.com/drugs/DB09030Approvedhimbacine-derived selective inhibitor of protease activated receptor (PAR-1) indicated for reducing the incidence of thrombotic cardiovascular events in patients with a history of myocardial infarction (MI … By inhibiting PAR-1, a thrombin receptor expressed on platelets, vorapaxar prevents thrombin-related platelet aggregation.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesSynonyms: [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-{(E)-2-[5-(3-Fluorophényl)-2-pyridinyl]vinyl}-1-méthyl-3-oxododécahydronaphto[2,3-c]furan-6-yl]carbamate d'éthyle, Carbamic acid, [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-fluorophenyl)-2- pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]-, ethyl esterResolvin E1
go.drugbank.com/drugs/DB13105InvestigationalResolvin E1 (RX 10001) is under investigation in clinical trial NCT00941018 (Single and Multiple Ascending Oral Dose Study of Resolvin E1 in Healthy Volunteers).
Synonyms: 5S,12R,18R-TRIHYDROXY-6Z,8E,10E,14Z,16E-EICOSAPENTAENOIC ACID, (5S,6Z,8E,10E,12R,14Z,16E,18R)-5,12,18-TRIHYDROXY-6,8,10,14,16-EICOSAPENTAENOIC ACIDSalts: TP-3173-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol
go.drugbank.com/drugs/DB07079ExperimentalSynonyms: 3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol